Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
Journal of Clinical Pathology|September 2, 2018
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovaryAhmed El-Balat, Iryna Schmeil, Khayal Gasimli, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokineticsR Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, et al.
Breast Cancer Research and Treatment|May 21, 2009
Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancerThomas Karn, Dirk Metzler, Eugen Ruckhäberle, et al.
Zentralblatt Fur Gynakologie|May 5, 2006
Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signaturesA Rody, T Karn, R Gätje, et al.
Journal of Lipid Mediators|March 1, 1993
BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokineticsR Müller-Peddinghaus, R Fruchtmann, H J Ahr, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2008
Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysisAchim Rody, Thomas Karn, Eugen Ruckhäberle, et al.
Breast Cancer Research and Treatment|December 18, 2012
Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypesLars C Hanker, Achim Rody, Uwe Holtrich, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Prognostic impact of thymidine phosphorylase expression in breast cancer--comparison of microarray and immunohistochemical dataE Ruckhäberle, T Karn, K Engels, et al.
Leukemia Research|April 15, 2021
Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapyJacob L Glass, Andriy Derkach, Patrick Hilden, et al.
Nature Communications|June 15, 2019
Spectral phase control of interfering chirped pulses for high-energy narrowband terahertz generationSpencer W Jolly, Nicholas H Matlis, Frederike Ahr, et al.
Pageof 23